SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Paul Robeson — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientPaul Robeson
Date of birth1898-04-09
IdentifiersMRN HR-ML048-SYN-TD; SSN (made up) 000-48-2647
Document date1957-10-05
AuthorTheodore Bankole-Ashworth, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Mr. Robeson is a 59-year-old singer and actor with recurrent major depression who comes for the preventive visit booked in the spring. Six weeks ago aripiprazole was added to venlafaxine 225 mg; he has taken 5 mg each morning for four weeks. He sleeps about six and a half hours, his energy and interest have come back, and he practices every morning and sang at two community gatherings last month. He has noticed no restlessness, stiffness or tremor; his weight is up 1.4 kg in six weeks. The cough from the summer cleared within three weeks. He continues weekly behavioral activation and is planning a small recital. He has had no thoughts of suicide. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 59
DepressionPHQ-9 6 on venlafaxine and aripiprazole
Side effectsNo restlessness or movement problems; weight up 1.4 kg
SafetyNo thoughts of suicide; safety plan in place

Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him by Dr. Bankole-Ashworth. [S]

DomainFinding
Self-rated healthGood and improving
PsychosocialPersecution and loss of income remain his main stresses; he feels stronger in facing them; supported by friends and his therapist
Substance useAUDIT-C 1 at intake, unchanged; no drug use
TobaccoNever smoked
Physical activityWalks 40 minutes most mornings; swimming twice a week again
NutritionRegular meals; more vegetables and less fried food since the lipid results
SleepAbout six and a half hours; no snoring reported; STOP-BANG 2
SafetyNo firearm at home; seat belt always; medicines kept in a locked box
Sexual healthOne partner; no concerns
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever; weight up 1.4 kg in six weeks
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeVoice clear; no hearing loss
CardiovascularNegativeNo chest pain or palpitations
RespiratoryNegativeCough gone
GastrointestinalNegativeNo change in bowel habit or bleeding
GenitourinaryNegativeNo difficulty passing urine; no nighttime frequency
MusculoskeletalNegativeNo joint pain
NeurologicalNegativeNo tremor, stiffness or restlessness
IntegumentaryNegativeNo rash
PsychiatricPositiveMild low mood on some days; no thoughts of suicide; PHQ-9 6

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg tablet, one tablet each morning50 mg each morning for two weeksOral route1957-03-12 to 1957-03-25completedS
Sertraline 100 mg tablet, one tablet each morning100 mg each morningOral route1957-03-26 to 1957-04-19completedS
Sertraline 50 mg tablets, three tablets (150 mg) each morning150 mg each morning for two weeksOral route1957-04-20 to 1957-05-03completedS
Sertraline 100 mg tablets, two tablets (200 mg) each morning200 mg each morningOral route1957-05-04 to 1957-06-07completedS
Sertraline 100 mg tablet, one tablet each morning for one week, then stop100 mg each morning for one week during the switchOral route1957-06-08 to 1957-06-14completedS
Venlafaxine extended-release 75 mg capsule, one capsule each morning with food75 mg each morning for one weekOral route1957-06-08 to 1957-06-14completedS
Venlafaxine extended-release 150 mg capsule, one capsule each morning with food150 mg each morning for three weeksOral route1957-06-15 to 1957-07-05completedS
Venlafaxine extended-release 75 mg capsules, three capsules (225 mg) each morning with food225 mg each morning; 30-day supply at a timeOral route1957-07-06activeS
Aripiprazole 2 mg tablet, one tablet each morning2 mg each morning for two weeksOral route1957-08-24 to 1957-09-06completedS
Aripiprazole 5 mg tablet, one tablet each morning5 mg each morningOral route1957-09-07activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1957-10-05Body height190cmS
1957-10-05Body weight102.4kgS
1957-10-05Body mass index (BMI) [Ratio]28.4kg/m2S
1957-10-05Systolic blood pressure130mm[Hg]S
1957-10-05Diastolic blood pressure80mm[Hg]S
1957-10-05Heart rate72/minS
1957-10-05Respiratory rate14/minS
1957-10-05Body temperature36.6CelS
1957-10-05Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1957-10-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 1957-10-05; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 102.4 kg, BMI 28.4; blood pressure 130/80
NeckNo lymph nodes; thyroid normal
CardiovascularRegular rhythm; no murmur
RespiratoryClear
AbdomenSoft; no mass
NeurologicalNo tremor, rigidity or abnormal movements; abnormal involuntary movement examination normal; no akathisia
PsychiatricWarm and engaged; affect fuller; speech at a normal pace

Problems

ProblemClinical statusVerificationCodeProvenance
About three months of low mood, exhaustion, poor sleep with waking at three in the morning, loss of interest in singing and reading, poor appetite with 5 kg weight loss, and withdrawal from friends, in a man of 58 under sustained political pressure; PHQ-9 22 with thoughts of being better off dead; depression suspected; medical causes being excluded and urgent psychiatric consultation arrangedresolvedconfirmed R53.83S — Synthetic presenting problem at intake, superseded by the diagnosis at the psychiatric consultation; anchored to his documented depression and loss of work (D).
Major depressive disorder, recurrent, severe, without psychotic features (second episode; structured diagnostic interview; MDQ negative and no past hypomanic or manic episode on interview)activeconfirmed F33.2S — Synthetic modern diagnosis anchored to his documented depression after the 1955 breakdown (D); the bipolar interpretation (R) is addressed and not adopted.
Sustained political persecution: passport withheld, concerts and recordings cancelled, income lost, and surveillance by federal agencies; a major and realistic stressor, not a delusionactiveconfirmed Z60.5S — Synthetic coding of his documented persecution as a social determinant of his depression.
Acute bronchitis after a cold, without signs of pneumonia; treated without antibiotics and without dextromethorphan or decongestants because of venlafaxine; resolvedresolvedconfirmed J20.9S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today130/80 mmHg; watched on venlafaxine
Depression screening and follow-upCompleted todayPHQ-9 6 under treatment; item 9 scored 0
Unhealthy alcohol use screeningUp to dateAUDIT-C 1 at intake; no change
Tobacco useCompleted todayNever smoked
Colorectal cancer screeningOrderedNo earlier screening; he chose a yearly FIT over colonoscopy; kit given today
Prostate cancer screeningDueShared decision due: he had prostate surgery about two years ago whose reason is not in this chart; records requested before discussing PSA testing
Lipid screening and statin assessmentCompleted todayTotal cholesterol 204, HDL 46, LDL 132 mg/dL six weeks ago; pooled cohort ten-year risk about 9 percent; statin offered after discussion; he chose diet and activity first, to revisit in a year
Diabetes screeningUp to dateA1c 5.6% six weeks ago; repeat at twelve weeks of aripiprazole
Lung cancer screeningNot indicatedNever smoked
HIV screeningUp to dateNegative at intake
Hepatitis C screeningOrderedOnce for adults; drawn today
Hepatitis B screeningOrderedOnce for all adults; drawn today; vaccination to follow if not immune
Influenza vaccineCompleted todaySeasonal dose
Pneumococcal vaccineCompleted todayPCV20, recommended from age 50
Zoster vaccineCompleted todayRecombinant vaccine dose 1 of 2
Tetanus, diphtheria, and pertussisUp to dateTdap six years ago on his card
COVID-19 vaccineDueDiscussed; he will decide at the next visit
Hepatitis B vaccineDueAfter the screening result, if not immune

Immunizations given today: Influenza vaccine, inactivated, trivalent, preservative-free; Pneumococcal conjugate vaccine, 20-valent (PCV20); Zoster vaccine, recombinant, dose 1 of 2 [S]

Guideline basis: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Colorectal Cancer: Screening (2021); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022); Adult Immunization Schedule by Age (2026)

Follow-up: Mood review with weight in two weeks, at eight weeks of aripiprazole; twelve-week metabolic tests. FIT result and screening results by phone. Second zoster dose in two to six months. Call or text 988 at any time in a crisis. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment of any illness. He named a health care agent, recorded in the confidential part of the chart and not named here. He asked that any future decision about ECT be his own, made with his own informed consent while he has capacity; this was recorded as his stated preference. To be revisited yearly. [S]